Clinical Trial Update: Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial is updating to add venetoclax to a combined hematopoietic stem cell and kidney transplantation protocol, with the study currently not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hematologic Cancer

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Kidney Failure Chronic, Stem Cell Transplant | EARLY_Phase 1 | Status: NOT_YET_RECRUITING